ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)
Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –
ANI Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
ANI Pharmaceuticals's cash was $360.21M at Jun 30, 2026. For fiscal 2025 it was $285.59M, up 97.1% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is $285.59M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $285.59M | +97.1% |
| FY2024 | Dec 31, 2024 | $144.89M | -34.5% |
| FY2023 | Dec 31, 2023 | $221.12M | +358.5% |
| FY2022 | Dec 31, 2022 | $48.23M | -51.9% |
| FY2021 | Dec 31, 2021 | $100.30M | +1175.4% |
| FY2020 | Dec 31, 2020 | $7.86M | -87.4% |
| FY2019 | Dec 31, 2019 | $62.33M | +44.9% |
| FY2018 | Dec 31, 2018 | $43.01M | +38.1% |
| FY2017 | Dec 31, 2017 | $31.14M | +13.8% |
| FY2016 | Dec 31, 2016 | $27.37M | -82.3% |
| FY2015 | Dec 31, 2015 | $154.68M | -8.5% |
| FY2014 | Dec 31, 2014 | $169.04M | +1422.2% |
| FY2013 | Dec 31, 2013 | $11.11M | +100854.5% |
| FY2012 | Dec 31, 2012 | $11.00K | – |
| FY2011 | Dec 31, 2011 | $0 | -100.0% |
| FY2010 | Dec 31, 2010 | $38.16M | +27.8% |
| FY2009 | Dec 31, 2009 | $29.86M | +153.9% |
| FY2008 | Dec 31, 2008 | $11.76M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $360.21M | +65.4% |
| Q1 FY2026 | Mar 31, 2026 | $311.18M | +107.7% |
| Q4 FY2025 | Dec 31, 2025 | $285.59M | +97.1% |
| Q3 FY2025 | Sep 30, 2025 | $262.61M | +81.1% |
| Q2 FY2025 | Jun 30, 2025 | $217.83M | -9.3% |
| Q1 FY2025 | Mar 31, 2025 | $149.80M | -34.5% |
| Q4 FY2024 | Dec 31, 2024 | $144.89M | -34.5% |
| Q3 FY2024 | Sep 30, 2024 | $144.98M | -24.9% |
| Q2 FY2024 | Jun 30, 2024 | $240.11M | +48.5% |
| Q1 FY2024 | Mar 31, 2024 | $228.60M | +237.4% |
| Q4 FY2023 | Dec 31, 2023 | $221.12M | +358.5% |
| Q3 FY2023 | Sep 30, 2023 | $193.08M | +243.1% |
| Q2 FY2023 | Jun 30, 2023 | $161.71M | +155.1% |
| Q1 FY2023 | Mar 31, 2023 | $67.76M | -11.9% |
| Q4 FY2022 | Dec 31, 2022 | $48.23M | -51.9% |
| Q3 FY2022 | Sep 30, 2022 | $56.28M | +269.0% |
| Q2 FY2022 | Jun 30, 2022 | $63.39M | +161.3% |
| Q1 FY2022 | Mar 31, 2022 | $76.91M | +206.7% |
| Q4 FY2021 | Dec 31, 2021 | $100.30M | +1175.4% |
| Q3 FY2021 | Sep 30, 2021 | $15.25M | -14.8% |
| Q2 FY2021 | Jun 30, 2021 | $24.26M | -12.4% |
| Q1 FY2021 | Mar 31, 2021 | $25.07M | +22.8% |
| Q4 FY2020 | Dec 31, 2020 | $7.86M | -87.4% |
| Q3 FY2020 | Sep 30, 2020 | $17.90M | -70.0% |
| Q2 FY2020 | Jun 30, 2020 | $27.70M | -31.7% |
| Q1 FY2020 | Mar 31, 2020 | $20.41M | -46.6% |
| Q4 FY2019 | Dec 31, 2019 | $62.33M | +44.9% |
| Q3 FY2019 | Sep 30, 2019 | $59.67M | +35.2% |
| Q2 FY2019 | Jun 30, 2019 | $40.59M | -26.2% |
| Q1 FY2019 | Mar 31, 2019 | $38.23M | -26.4% |
| Q4 FY2018 | Dec 31, 2018 | $43.01M | +38.1% |
| Q3 FY2018 | Sep 30, 2018 | $44.14M | +144.8% |
| Q2 FY2018 | Jun 30, 2018 | $54.99M | +557.1% |
| Q1 FY2018 | Mar 31, 2018 | $51.97M | +380.0% |
| Q4 FY2017 | Dec 31, 2017 | $31.14M | +13.8% |
| Q3 FY2017 | Sep 30, 2017 | $18.03M | +11.6% |
| Q2 FY2017 | Jun 30, 2017 | $8.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.83M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.37M | – |
| Q3 FY2016 | Sep 30, 2016 | $16.16M | – |
See a number that looks wrong?